✦ LIBER ✦

A Phase 1 dose-escalation trial of glufosfamide in combination with gemcitabine in solid tumors including pancreatic adenocarcinoma

✍ Scribed by E. Gabriela Chiorean; Tomislav Dragovich; John Hamm; Virginia K. Langmuir; Stewart Kroll; Donald T. Jung; Alan B. Colowick; George F. Tidmarsh; Patrick J. Loehrer

Publisher: Springer
Year: 2007
Tongue: English
Weight: 312 KB
Volume: 61
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0559-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I, dose escalation trial of ZD04

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine

✍ KeithT. Flaherty; JamesP. Stevenson; Maryann Redlinger; KennethM. Algazy; Bruce 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 172 KB

A phase I trial of gemcitabine in combin

A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors

✍ William Schelman; Sherry Morgan-Meadows; Howard Bailey; Kyle Holen; James P. Tho 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 325 KB

Phase I clinical trial of bortezomib in

Phase I clinical trial of bortezomib in combination with gemcitabine in patients with advanced solid tumors

✍ David P. Ryan; Leonard J. Appleman; Thomas Lynch; Jeffrey G. Supko; Panagiotis F 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Abstract ## BACKGROUND. Bortezomib is the first proteasome inhibitor to show preliminary evidence of activity against solid tumors. Findings from preclinical studies prompted a Phase I trial to determine the maximum tolerated dose (MTD) and dose‐limiting toxicities (DLTs) of bortezomib in combi

Sunitinib in combination with docetaxel

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study

✍ Francisco Robert; Alan Sandler; Joan H. Schiller; Glenn Liu; Karen Harper; Lev V 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 233 KB

Phase I dose-escalating study of biweekl

Phase I dose-escalating study of biweekly fixed-dose rate gemcitabine plus pemetrexed in patients with advanced solid tumors

✍ Yuan Yuan; Deirdre J. Cohen; Erica Love; Michelle Yaw; Benjamin Levinson; Steven 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 289 KB

Phase I dose-escalation study of tezacit

Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors

✍ Johanna C. Bendell; Joseph P. Eder; Jeffrey W. Clark; Panagiotis Fidias; Thomas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views